SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-025101
Filing Date
2021-05-06
Accepted
2021-05-06 17:00:32
Documents
3
Period of Report
2021-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K harp-8k_20210504.htm 8-K 51445
2 EX-99.1 harp-ex991_6.htm EX-99.1 137409
3 GRAPHIC gwdjp01pcozf000001.jpg GRAPHIC 29892
  Complete submission text file 0001564590-21-025101.txt   231468
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38800 | Film No.: 21898755
SIC: 2836 Biological Products, (No Diagnostic Substances)